FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve clinical outcomes and QOL.

At every moment,  God is giving us what we need to know to find freedom from illness.

There are many different medications to help with pain. Drugs in the non-opioid group are non-habit-forming and can address pain in various areas of the body. Non-opioid pain medications provide ...

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

Acute myocarditis is associated with worse short-term and long-term survival outcomes than unexplained chest pain, although ...

A rheumatologist discusses how her understanding of chronic pain in PsA has evolved—and how it affects her approach to ...

This World Liver Day, health experts are raising alarms about the hidden dangers of casually popping painkillers. Often taken ...

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, but overall evidence for pain outcomes in these patients is low, according ...

Chronic pain—or pain that lasts at least three months—is closely intertwined with depression. Individuals living with pain's ...

Though frustrating and difficult, hip pain is often preventable—and even when it isn't, it's nearly always treatable.

It will be sold under the brand name Journavx (JOUR-nah-vix) to treat moderate to severe, acute, short-term pain in adults. It was approved Jan. 30, but is not available for prescription yet.